• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性氧与黑色素瘤:能否解释生存性别差异?

Reactive oxygen species and melanoma: an explanation for gender differences in survival?

机构信息

Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands.

出版信息

Pigment Cell Melanoma Res. 2010 Jun;23(3):352-64. doi: 10.1111/j.1755-148X.2010.00694.x. Epub 2010 Mar 10.

DOI:10.1111/j.1755-148X.2010.00694.x
PMID:20218981
Abstract

Epidemiological research consistently shows a female advantage in melanoma survival. So far, no definite candidate for the explanation of this phenomenon has emerged. We propose that gender differences in oxidative stress caused by radical oxygen species (ROS) underlie these survival differences. It is known that males express lower amounts of anti-oxidant enzymes, resulting in more oxidative stress than females. The primary melanoma environment is characterized by high ROS levels, from exogenous sources as well as ROS production within melanoma cells themselves. ROS are known to be able to promote metastasis through a wide variety of mechanisms. We hypothesize that the higher levels of ROS in men enhance selection of ROS-resistance in melanoma cells. Subsequently, ROS can stimulate the metastatic potential of melanoma cells. In addition, due to the lower anti-oxidant defenses in men, ROS produced by melanoma cells cause more damage to healthy tissues surrounding the tumor, further stimulating metastasis. Therefore, ROS may explain the observed differences between males and females in melanoma survival.

摘要

流行病学研究一直表明,女性在黑色素瘤生存方面具有优势。到目前为止,还没有出现明确的候选解释来解释这一现象。我们提出,由活性氧(ROS)引起的氧化应激的性别差异是导致这些生存差异的基础。众所周知,男性表达的抗氧化酶较少,导致氧化应激水平高于女性。原发性黑色素瘤环境的特征是 ROS 水平较高,既有来自外源性的 ROS,也有黑色素瘤细胞自身产生的 ROS。ROS 已知能够通过多种机制促进转移。我们假设男性体内较高水平的 ROS 增强了黑色素瘤细胞对 ROS 的抗性选择。随后,ROS 可以刺激黑色素瘤细胞的转移潜能。此外,由于男性的抗氧化防御能力较低,黑色素瘤细胞产生的 ROS 会对肿瘤周围的健康组织造成更大的损害,从而进一步刺激转移。因此,ROS 可能解释了黑色素瘤生存中观察到的男性和女性之间的差异。

相似文献

1
Reactive oxygen species and melanoma: an explanation for gender differences in survival?活性氧与黑色素瘤:能否解释生存性别差异?
Pigment Cell Melanoma Res. 2010 Jun;23(3):352-64. doi: 10.1111/j.1755-148X.2010.00694.x. Epub 2010 Mar 10.
2
Reactive oxygen species in melanoma and its therapeutic implications.黑色素瘤中的活性氧及其治疗意义。
Melanoma Res. 2007 Dec;17(6):400-9. doi: 10.1097/CMR.0b013e3282f1d312.
3
Free radicals, metals and antioxidants in oxidative stress-induced cancer.氧化应激诱导癌症中的自由基、金属与抗氧化剂
Chem Biol Interact. 2006 Mar 10;160(1):1-40. doi: 10.1016/j.cbi.2005.12.009. Epub 2006 Jan 23.
4
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma.双硫仑诱导铜依赖性活性氧的刺激和黑色素瘤细胞外凋亡途径的激活。
Melanoma Res. 2010 Feb;20(1):11-20. doi: 10.1097/CMR.0b013e328334131d.
5
Reactive oxygen species: an Achilles' heel of melanoma?活性氧:黑色素瘤的致命弱点?
Expert Rev Anticancer Ther. 2008 Nov;8(11):1751-7. doi: 10.1586/14737140.8.11.1751.
6
Influence of therapy on the antioxidant status in patients with melanoma.治疗对黑色素瘤患者抗氧化状态的影响。
J Clin Pharm Ther. 2008 Apr;33(2):179-85. doi: 10.1111/j.1365-2710.2008.00909.x.
7
Effect of gender and sex hormones on vascular oxidative stress.性别及性激素对血管氧化应激的影响。
Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1037-43. doi: 10.1111/j.1440-1681.2007.04732.x.
8
Reactive oxygen species in tumor metastasis.肿瘤转移中的活性氧物种
Cancer Lett. 2008 Jul 18;266(1):53-9. doi: 10.1016/j.canlet.2008.02.031. Epub 2008 Mar 24.
9
Oxidative stress in melanocyte senescence and melanoma transformation.黑素细胞衰老和黑色素瘤转化中的氧化应激。
Eur J Cell Biol. 2014 Jan-Feb;93(1-2):36-41. doi: 10.1016/j.ejcb.2013.11.005. Epub 2013 Nov 23.
10
Cells discover fire: employing reactive oxygen species in development and consequences for aging.细胞发现了火:活性氧在发育过程中的作用及对衰老的影响。
Exp Gerontol. 2006 Jan;41(1):1-10. doi: 10.1016/j.exger.2005.09.002. Epub 2005 Oct 12.

引用本文的文献

1
Sex differences in melanoma survival-a GEM study.黑色素瘤生存中的性别差异——一项基因组流行病学研究
JNCI Cancer Spectr. 2025 Jan 3;9(1). doi: 10.1093/jncics/pkaf005.
2
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019.评估全球、区域和国家层面皮肤恶性黑色素瘤护理质量:1990 年至 2019 年全球疾病负担研究的系统分析。
Arch Dermatol Res. 2023 Dec;315(10):2893-2904. doi: 10.1007/s00403-023-02730-2. Epub 2023 Sep 29.
3
Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival.
与癌症易感性和生存率相关的氧化应激中的性别差异
Antioxidants (Basel). 2023 Jun 11;12(6):1255. doi: 10.3390/antiox12061255.
4
Risk of Cardiovascular Disease Death in Older Malignant Melanoma Patients: A Population-Based Study.老年恶性黑色素瘤患者心血管疾病死亡风险:一项基于人群的研究。
Cancers (Basel). 2022 Sep 30;14(19):4783. doi: 10.3390/cancers14194783.
5
Effect of Aspirin on Melanoma Incidence in Older Persons: Extended Follow-up of a Large Randomized Double-blind Placebo-controlled Trial.阿司匹林对老年人黑色素瘤发病率的影响:一项大型随机双盲安慰剂对照临床试验的延长随访。
Cancer Prev Res (Phila). 2022 Jun 2;15(6):365-375. doi: 10.1158/1940-6207.CAPR-21-0244.
6
Let's talk about sex: A biological variable in immune response against melanoma.让我们谈谈性:免疫应答对黑色素瘤的生物学变量。
Pigment Cell Melanoma Res. 2022 Mar;35(2):268-279. doi: 10.1111/pcmr.13028. Epub 2022 Feb 3.
7
Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.性别差异与皮肤黑色素瘤:发病率、临床病理特征、生存率和费用。
J Womens Health (Larchmt). 2022 Jul;31(7):1012-1019. doi: 10.1089/jwh.2021.0223. Epub 2022 Jan 25.
8
Cutaneous melanoma: a retrospective study of 18 years. Are there gender differences?皮肤黑色素瘤:一项为期18年的回顾性研究。存在性别差异吗?
An Bras Dermatol. 2021 Sep-Oct;96(5):619-623. doi: 10.1016/j.abd.2020.08.022. Epub 2021 Jul 18.
9
Features associated with melanoma metastasis in Latvia.拉脱维亚黑色素瘤转移相关特征。
Oncol Lett. 2020 Oct;20(4):117. doi: 10.3892/ol.2020.11978. Epub 2020 Aug 12.
10
Gender Differences and Outcomes in Melanoma Patients.黑色素瘤患者的性别差异与预后
Oncol Ther. 2020 Jun;8(1):103-114. doi: 10.1007/s40487-020-00109-1. Epub 2020 Feb 4.